Canada markets closed

RIV Capital Inc. (CNPOF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5400+0.0146 (+2.78%)
At close: 02:23PM EDT

RIV Capital Inc.

40 King Street West
Suite 2504
Toronto, ON M5H 3Y2

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Edward James Cirillo LucarelliChief Financial Officer415.93kN/A1988
Mr. Matthew Jonathon MundyChief Strategy Officer, Gen. Counsel & Corp. Sec.388.2kN/A1984
Mr. Mark SimsPres, CEO & DirectorN/AN/AN/A
Mr. Peter HatziioannouCo-Founder & AdvisorN/AN/AN/A
Mr. Sean McNultyCo-Founder & AdvisorN/AN/AN/A
Mr. Mike TotzkeChief Operating OfficerN/AN/AN/A
Ms. Mary DimouSr. Director of Corp. Devel.N/AN/AN/A
Mr. Mark CavdarDirector of Market Intelligence & Regulatory AffairsN/AN/AN/A
Mr. Alac KimDirector of Corp. Devel.N/AN/AN/A
Mr. Adam PopeAnalystN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.

Corporate Governance

RIV Capital Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.